Skip to main content

Advertisement

Table 6 Number of daily rapid-acting insulin injections, biphasic or glargine insulin and total daily insulin dose after the end of the monitoring period

From: Intensification of insulin therapy in patients with type 2 diabetes: a retrospective, non- interventional cohort study of patients treated with insulin glargine or biphasic human insulin in daily clinical practice

  Control group Active group p-value
Number of insulin injections, n (%)    
1 16 (10.1) 45 (31.7)
2 85 (53.5) 20 (14.1)
3 58 (36.5) 27 (19.0) <0.001
4 0 (0.0) 49 (34.5)  
5 0 (0.0) 1 (0.7)
Mean ± SD daily units of rapid acting insulin (U/day) 9.5 ± 2.3 23.3 ± 18.4 <0.001
Mean ± SD daily units of rapid acting insulin (U/Kg/day) 0.12 ± 0.03 0.29 ± 0.23 <0.001